Andreas Caduff, PhD, was born in 1971 and is a Swiss citizen. He held various positions in the pharmaceutical and medical device industry. In his previous position he was serving as CTO of Solianis, where he orchestrated the overall technology and product development, experimental/ clinical study strategies, regulatory considerations, interaction with the industrial/scientific community, regulatory bodies as well as the investor’s community.
He is an expert in physiological monitoring techniques and involved physiological/metabolic processes, combining the expertise in various fields relevant to the development, industrialisation and commercialisation of wearable monitoring technologies.
Andreas Caduff is a frequent invited speaker at industrial and scientific conferences and meetings on physiological monitoring, mobile health and related subjects. He has innovated numerous patents and co-authored several dozen scientific publications in peer reviewed journals.
In 2011, he founded Biovotion, an organisation developing specialised non-invasive physiological monitoring concepts and mHealth applications, where he is serving as CEO.